Trump's HHS pick could reshape public health agencies and usher in a new era for vaccines, food, and medicines.

EMA human medicine committee recommends approval of Sanofi’s Sarclisa to treat transplant-ineligible newly diagnosed multiple myeloma: Paris Saturday, November 16, 2024, 09:00 H ...

Kennedy is Trump’s pick for health secretary, but he has a history of spreading misinformation about a range of issues.

If confirmed as Health and Human Services Secretary, Robert F. Kennedy Jr. would implement sweep reforms at the world’s ...

Can we really achieve immortality? Explore the latest scientific breakthroughs, ethical dilemmas, and what the future might ...

Understanding how human neurons cope with the energy demands of a large, active brain could open up new avenues for treating ...

In a landmark continuing collaboration, Answer ALS and Cedars-Sinai have announced the completed availability of the largest amyotrophic lateral sclerosis (ALS) patient-based induced pluripotent stem ...

In a remarkable medical breakthrough, doctors have successfully used stem cells to treat a debilitating eye condition that ...

The ascension of Robert F. Kennedy Jr., a longtime anti-vaccine activist, to the nation’s top health post has alarmed medical ...

(Yicai) Nov. 15 -- The Germany’ Merck and five other overseas pharmaceutical companies have been given the green light to ...

LSCD is a debilitating eye condition where the cornea loses the adult stem cells responsible for repair and regeneration.

Two years after surgery, three patients experienced improved corneal transparency with no serious side effects.